ArticleBMC cancer2020

Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma.

Priya Sriskandarajah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.